Skip to main content

Advertisement

ADVERTISEMENT

Podcasts

Headshot of Alex Spira, Virginia Cancer Specialists Research Institute, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
10/08/2021
Maria Asimopoulos
Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...
Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...
Alex Spira, MD, PhD, FACP,...
10/08/2021
First Report Managed Care
Headshot of Peter Lio, MD, FAAD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
09/28/2021
Edan Stanley
Peter Lio, MD, FAAD, clinical assistant professor of dermatology & pediatrics, Northwestern University Feinberg School of Medicine, and founding director, Chicago Integrative Eczema Center, discusses the common challenges associated with...
Peter Lio, MD, FAAD, clinical assistant professor of dermatology & pediatrics, Northwestern University Feinberg School of Medicine, and founding director, Chicago Integrative Eczema Center, discusses the common challenges associated with...
Peter Lio, MD, FAAD, clinical...
09/28/2021
First Report Managed Care

Advertisement

Headshot of Jim Dean, AbbVie, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
09/24/2021
Maria Asimopoulos
Jim Dean, MD, PhD, Imbruvica global development lead and executive medical director, AbbVie, discusses data from the RESONATE-2 study showing that single-agent ibrutinib (Imbruvica) improved progression-free and overall survival for up to...
Jim Dean, MD, PhD, Imbruvica global development lead and executive medical director, AbbVie, discusses data from the RESONATE-2 study showing that single-agent ibrutinib (Imbruvica) improved progression-free and overall survival for up to...
Jim Dean, MD, PhD, Imbruvica...
09/24/2021
First Report Managed Care
Headshot of Gary Owens, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
09/24/2021
Edan Stanley
Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...
Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...
Gary Owens, MD, president of...
09/24/2021
First Report Managed Care
gil melmed md gastrolenterologst
Podcasts
09/23/2021
Julie Gould
According to Gil Melmed, MD, gastroenterologist, recurrent CDI is multifactorial, and when estimating the burden of this condition, both direct and indirect costs should be considered.
According to Gil Melmed, MD, gastroenterologist, recurrent CDI is multifactorial, and when estimating the burden of this condition, both direct and indirect costs should be considered.
According to Gil Melmed, MD,...
09/23/2021
First Report Managed Care

Advertisement

gil melmed md gastrolenterologst
Podcasts
08/12/2021
Julie Gould
Gil Melmed, MD, gastroenterologist, reviews the burden linked with recurrent Clostridioides difficile (CDI), provides need-to-know information for payers to better inform formulary placement, and discusses the direct and indirect costs linked...
Gil Melmed, MD, gastroenterologist, reviews the burden linked with recurrent Clostridioides difficile (CDI), provides need-to-know information for payers to better inform formulary placement, and discusses the direct and indirect costs linked...
Gil Melmed, MD,...
08/12/2021
First Report Managed Care
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health
Podcasts
08/06/2021
Julie Gould
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, discusses fundamental barriers within HIV care, and how the US health system can better manage the HIV epidemic, which...
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, discusses fundamental barriers within HIV care, and how the US health system can better manage the HIV epidemic, which...
Chris Beyrer, MD, infectious...
08/06/2021
First Report Managed Care

Advertisement

Headshot of Chris Clark on a blue background underneath the PopHealth Perspectives logo.
Podcasts
07/22/2021
Maria Asimopoulos
Chris Clark, global head of asset and commercial strategy, rare diseases, UCB, discusses UCB’s expanded efforts to treat patient populations with rare diseases, including UCB’s work on two investigational treatments for myasthenia gravis.
Chris Clark, global head of asset and commercial strategy, rare diseases, UCB, discusses UCB’s expanded efforts to treat patient populations with rare diseases, including UCB’s work on two investigational treatments for myasthenia gravis.
Chris Clark, global head of...
07/22/2021
First Report Managed Care
Headshot of Michael Thorpy, MD
Podcasts
07/14/2021
Julie Gould
Michael Thorpy, MD, reviews a study presented at the 2021 Sleep meeting that evaluated the efficacy of the investigational, once-nightly controlled-release formulation of sodium oxybate, known as FT218, for the treatment of excessive daytime...
Michael Thorpy, MD, reviews a study presented at the 2021 Sleep meeting that evaluated the efficacy of the investigational, once-nightly controlled-release formulation of sodium oxybate, known as FT218, for the treatment of excessive daytime...
Michael Thorpy, MD, reviews a...
07/14/2021
First Report Managed Care

Advertisement